Defective HIV-1 provirus encoding a multitarget-ribozyme inhibits accumulation of spliced and unspliced HIV-1 mRNAs, reduces infectivity of viral progeny, and protects the cells from pathogenesis

Human Gene Therapy
S Y PaikM Schubert

Abstract

A HeLa T4 cell line containing a defective human immunodeficiency virus type 1 (HIV-1) DNA (HD4) was isolated. After transactivation with Tat, the HD4 DNA was transcribed into a single 3.7-kb mRNA that encodes a chimeric CD4/Env protein and a multitarget-ribozyme directed against multiple sites within the gp120 coding region of HIV-1 RNA (Chen et al., 1992). Early steps in HIV infection such as entry, reverse transcription, and proviral DNA formation were not affected in HD4 cells, and HD4 was efficiently transactivated after either HIV-1 or HIV-2 infections. HIV-2, which lacks all of the HIV-1-specific ribozyme target sites, replicated to high levels in HD4 cells whereas HIV-1 replication was selectively inhibited. Despite a reduced accumulation of all HIV-1 transcripts, transactivation of HD4 was efficient. Surprisingly, the most abundant, multiply spliced mRNAs were reduced even though they lack all of the ribozyme target sites. These results strongly suggest that the ribozyme co-localizes with unspliced HIV-1 pre-mRNA and/or genomic HIV-1 RNA in the nucleus. Cleavage of these precursor RNAs explains the reduction of all spliced and unspliced HIV-1 RNAs. Cleavage of genomic RNA probably contributed to the three-fold reductio...Continue Reading

References

Mar 9, 1990·Science·N SarverJ J Rossi
Sep 1, 1995·Brain Research. Molecular Brain Research·K ImaizumiH Kiyama
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·G H CantorG H Palmer
Jun 25, 1995·Nucleic Acids Research·O HeidenreichM Nerenberg
Mar 21, 1995·Gene·G FerbeyreR Cedergren
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·H Y KwonR P Woychik
Jul 19, 1994·Proceedings of the National Academy of Sciences of the United States of America·H Kandolf
Jan 1, 1993·Journal of Virology·K E DolterT C Holland
Jan 1, 1993·Antisense Research and Development·B DropulicN Sarver

❮ Previous
Next ❯

Citations

Feb 1, 1995·Mathematical Biosciences·G W Nelson, A S Perelson
Nov 20, 1998·Current Opinion in Biotechnology·P J WelchF Wong-Staal
Feb 15, 2001·The Biochemical Journal·R Goila, A C Banerjea
Dec 12, 2012·Journal of Virology·Igor M Rouzine, Leor S Weinberger
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·S ShahiA C Banerjea
Jun 6, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Samitabh Chakraborti, Akhil C Banerjea
Nov 30, 2004·Nature Biotechnology·Hoshang J UnwallaJohn J Rossi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.